Möchten Sie immer auf dem neuesten Stand bleiben?

– Phase 1a study portion of single ascending dosing in healthy participants will inform the development of ABI-5366 with interim data expected in Q3 2024 – – Phase 1b study portion of multiple...

Retrieve Medical Announces Newly Issued Patent for Enhanced Problem List Management in EHR Systems

-- Poster highlights promising preclinical profile of ABI-6250 ahead of entry into the clinic, expected by end of 2024 -- SOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Assembly...

Retrieve Medical, Inc. Selected to Exhibit Retrieve DxTM at Vizient Innovative Technology Exchange

AUSTIN, Texas, June 04, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced today details of...

Gulf Breeze, FL, May 29, 2024 (GLOBE NEWSWIRE) -- Limitless Biotech, a leading provider of high-quality peptides, proudly announces its ascension as the best peptide company in the industry. Through...

New York, May 22, 2024 (GLOBE NEWSWIRE) -- Market Overview The Medical Polyoxymethylene Market size is expected to reach USD 133.6 million by 2024 and is further anticipated to value USD 253.5...

Burlingame, May 20, 2024 (GLOBE NEWSWIRE) -- CoherentMI published a report, titled, United States Ophthalmic Market was valued at US$ 15.90 Billion in the year 2023, and is anticipated to reach a...

AUSTIN, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that new...

Rome, GA, May 16, 2024 (GLOBE NEWSWIRE) -- Southeast Detox GA, a leading inpatient alcohol and drug addiction rehab center, is excited to announce that its Rome Georgia in-patient detox facility has...